ESTRO GUIDE 2017

Cancer Survivorship 21-23 May 2017 Brussels, Belgium

TARGET GROUP The course is primarily aimed at trainees in radiation oncology, supportive care personnel, radiation ther- apists (RTTs) and at radiation oncologists early in their career and/or eager to update their knowledge of general and organ specific morbidity aspects inmodern radio-(chemo-/targeted-) therapy. For PhD students in radiation oncology and related disciplines, this course can broaden their knowledge. As the focus is on clinical applications, the competences of the teachers’ team comprise radiation oncology, gastroenterology, psychology and radiobiology. COURSE AIM For the lectures, the aims are to: • Introduce general principles of normal tissue radio- pathogenesis and radiobiology • Provide approaches for assessment and documentation of treatment-related morbidity • Provide management strategies for “systemic” mor- bidity (nausea/emesis, fatigue) • Illustrate important facets of treatment-/morbidity-re- lated quality of life (including assessment instruments) and emotional dysfunction • Provide a comprehensive overview over relevant and currently accepted approaches for prevention, mitiga- tion and treatment of adverse events and supportive care • Detail specific aspects of morbidity in abdominal and pelvic radiation oncology (gastrointestinal tract including. liver and pancreas, urinary tract including kidney, sexual organs and function). Complimentary to the lectures, general discussion sessions and clinical case presentations will serve to illustrate the relevance of the various aspects of mor- bidity for daily clinical work, and to answer specific (morbidity-related) questions.

ment-related morbidity • Identify, classify and document treatment-related morbidity in cancer survivors • Identify the impact of treatment-related morbidity on patients’ quality of life • Provide strategies for management of systemic morbidity • Provide strategies for prevention of treatment-related morbidity • Provide supportive care and organ-specific morbidity management to cancer survivors. COURSE CONTENT 1. General lectures on: • The relevance of treatment-related morbidity for cancer survivors • General pathogenesis of normal tissue reactions • Classification and documentation of morbidity • Reporting: prevalence vs. incidence • Impact of exposure parameters (4 R’s of radiotherapy) • Volume effects and tolerance concepts • General morbidity: fatigue, nausea and emesis • Quality of life: general aspects, documentation • Psychological disorders/emotional dysfunction • Coping with disease and post-disease life • Management and supportive care guidelines • Specific aspects of chemo-/immunotherapy. 2. Module-specific lectures on: • Skin and adnexae • Spinal cord, peripheral nerves • Gastrointestinal tract • Liver and pancreas • Urinary tract, including kidneys • Sexual organs and function • Aspects of paediatric (radio-)oncology. 3. Clinical case discussions: The participants are invited to collectively discuss expected (based on treatment protocol and planning) morbidity and to develop management strategies of observed adverse events in clinical cases prepared by the faculty and/or put forward by participants.

LEARNINGOUTCOMES By the end of this course participants should be able to: • Understand the underlying (radio)biology of treat-

48

ESTRO SCHOOL